Real-time enrollment status for this high-risk muscle invasive urothelial carcinoma clinical trial
Current Status
Recruiting
Checked: July 23, 2026 at 2:55 AM UTC
| NCT Number | NCT07720284 |
| Recruiting Status | Recruiting |
| Condition | High-risk Muscle Invasive Urothelial Carcinoma |
| Phase | PHASE3 |
| Target Enrollment | 915 participants |
| Active Locations | 19 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | July 22, 2026 (Yesterday) |
As of July 23, 2026: Clinical trial NCT07720284 is currently recruiting participants. This phase3 study for high-risk muscle invasive urothelial carcinoma is actively seeking new participants at 19 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07720284 is actively recruiting participants as of July 23, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07720284 was last updated Yesterday (July 22, 2026). HelloStudys verifies this status automatically.